Search Results - "Luik, Anne Marije"

Biodistribution of 18F-FES in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant (G1T48), a Novel Selective ER Degrader by Iqbal, Ramsha, Yaqub, Maqsood, Oprea-Lager, Daniela E, Liu, Yeukman, Luik, Anne Marije, Beelen, Andy P, Schuit, Robert C, Windhorst, Albert D, Boellaard, Ronald, Menke-van der Houven van Oordt, Catharina W

“…16α-18F-fluoro-17β-estradiol (18F-FES) is a PET tracer characterizing the expression of the estrogen receptor (ER). Because therapy can interfere with the…”
Get full text

Biodistribution of 18 F-FES in patients with metastatic ER+ breast cancer undergoing treatment with Rintodestrant (G1T48), a novel selective estrogen receptor degrader by Iqbal, Ramsha, Yaqub, Maqsood, Oprea-Lager, Daniela E, Liu, Yeukman, Luik, Anne Marije, Beelen, Andy, Schuit, Robert, Windhorst, Albert, Boellaard, Ronald, Menke-van der Houven van Oordt, Catharina W

Get full text

A phase 1 study of weekly high dose sunitinib in patients with advanced solid tumors: Early signs of activity in non-RCC tumor types by Rovithi, Maria, Voortman, Johannes, Luik, Anne Marije, Ruijter, Rita, de Haas, Richard, Honeywell, Richard, Labots, Mariette, Poel, Dennis, Peters, Godefridus J., Griffioen, Arjan W., Verheul, Henk M.W.

“…Abstract only…”
Get full text

Biodistribution of 18 F-FES in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant (G1T48), a Novel Selective ER Degrader by Iqbal, Ramsha, Yaqub, Maqsood, Oprea-Lager, Daniela E, Liu, Yeukman, Luik, Anne Marije, Beelen, Andy P, Schuit, Robert C, Windhorst, Albert D, Boellaard, Ronald, Menke-van der Houven van Oordt, Catharina W

“…16α- F-fluoro-17β-estradiol ( F-FES) is a PET tracer characterizing the expression of the estrogen receptor (ER). Because therapy can interfere with the…”
Get full text

Abstract 2989: High-dose, intermittent sunitinib as an alternative treatment strategy by Rovithi, Maria, Haas, Richard R. de, Honeywell, Richard J., Voortman, Johannes, Griffioen, Arjan W., Labots, Mariette, Luik, Anne Marije, Peters, Godefridus J., Broxterman, Henk J., Verheul, Henk M.w.

“…Background: Increased exposure to sunitinib treatment is associated with improved outcome indicative of the importance of dose intensity in the…”
Get full text

89Zr-cetuximab PET imaging in patients with advanced colorectal cancer by Menke-van der Houven van Oordt, Catharina Willemien, Gootjes, Elske C, Huisman, Marc C, Vugts, Danielle J, Roth, Chantal, Luik, Anne Marije, Mulder, Emma R, Schuit, Robert C, Boellaard, Ronald, Hoekstra, Otto S, van Dongen, Guus Ams, Verheul, Henk M W

“…Monoclonal antibodies (mAbs) against the epidermal growth factor receptor (EGFR) are used in the treatment of advanced colorectal cancer (mCRC). Approximately…”
Get full text